Minnow Street Minnow Street
Buy Day today: Neutral (53) Mixed market breadth · no major macro event

Indivior Pharmaceuticals, Inc. (INDV)

Healthcare Drug Manufacturers - Specialty & Generic
40.00 $
-0.5% vs. previous close
Closing price · As of: 31. Jul 2026

Who owns Indivior Pharmaceuticals, Inc. (INDV)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 95.5% of the shares are freely tradable; institutional investors hold 107.5%.

Ownership Structure

Institutional ownership
107.5%
Insiders
4.8%
Float
95.5%
Short % of float
11.9%
Shares Outstanding
118Mio.

Largest Shareholders

Institutions

Institutions INDV
Name Stake (%) Shares Change (%) Date
BlackRock Inc 15.69 18,542,220 +1.7 03/31/2026
Vanguard Portfolio Management, LLC 6.68 7,891,819 +0.0 03/31/2026
Oaktree Capital Management LLC 5.91 6,984,102 +0.0 03/31/2026
Vanguard Capital Management, LLC 4.73 5,586,576 +0.0 03/31/2026
State Street Corp 4.15 4,903,993 +0.0 03/31/2026
Two Seas Capital LP 4.02 4,746,510 +0.0 03/31/2026
Millennium Management LLC 3.89 4,595,535 +0.0 03/31/2026
Fuller & Thaler Asset Management Inc 3.83 4,529,583 +0.0 03/31/2026
Madison Avenue Partners, LP 3.65 4,315,162 -31.3 03/31/2026

Funds

Funds INDV
Name Stake (%) Shares Change (%) Date
iShares Core S&P Small-Cap ETF 6.43 7,598,725 +0.0 05/29/2026

Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.

Insider Transactions

Insider Transactions
Date Person Role Type Shares Price Value
10. Jul 2026 Heidbreder Christian Chief Scientific Officer Sell 18,586 41.14 764,628

Reportable transactions by officers and major shareholders from SEC Form 4 filings. "Other" includes things like stock grants and option exercises without a buy/sell character.

View all insider transactions →

Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?